INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹36 Cr | ₹34 Cr | ₹33 Cr | ₹32 Cr | ₹66 Cr |
What is the latest Long Term Provisions ratio of INDOCO REMEDIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹66 Cr |
How is Long Term Provisions of INDOCO REMEDIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | 6.35 | |
| Mar2024 | ₹34 Cr | 0.86 | |
| Mar2023 | ₹33 Cr | 5.20 | |
| Mar2022 | ₹32 Cr | -52.15 | |
| Mar2021 | ₹66 Cr | - | |
Compare Long Term Provisions of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,257.2 Cr | 4.4% | 16.8% | -17.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 4.4% |
16.8% |
-17.4% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses